Financials
Financial year 2026
TERUMO EUROPE from Leuven, company number BE0408270327, closed financial year 2026 with a result of € 12.1 million after tax. For that financial year TERUMO EUROPE recorded revenue of € 799.2 million and equity of € 590.9 million. Compared with financial year 2025, the result moved from € -24.7 million to € 12.1 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.
€ 590.9 million
▲ 29% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 12.1 million
▲ still € 24.7 million loss in 2025
Profit after tax over the fiscal year.
€ 9.5 million
▲ 35% vs 2025
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2026. Retained profit grew to € 174.9 million.
People and assets in 2026
721.3
▼ 53.8 vs 2025
Average over the fiscal year, from the social balance sheet.
€ 82.2 million
€ 113,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1.9 million
▲ 11% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
€ 28 million
Loans from banks and other lenders, long and short.
€ 257.8 million
▼ 8% vs 2025
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 134 days on average.
€ 23.1 million
▼ 31% vs 2025
Taxes, VAT and social contributions still to pay.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Revenue | € 664,933,258 | € 718,349,806 | € 761,119,765 | € 799,237,192 | ▲ 5% |
| Profit after taxes | € 42,565,973 | € 45,172,425 | € -24,674,205 | € 12,097,199 | ▲ € 36.8 million |
| Equity | € 482,269,247 | € 483,441,672 | € 458,767,467 | € 590,864,667 | ▲ 29% |
| Total debts | € 273,173,272 | € 367,976,652 | € 385,829,417 | € 372,821,808 | ▼ 3% |
| Cash | € 10,463,818 | € 10,015,133 | € 7,072,340 | € 9,521,115 | ▲ 35% |
| Land & buildings | € 8,174,317 | € 10,108,584 | € 13,647,413 | € 15,201,548 | ▲ 11% |
| Retained profit | € 186,306,831 | € 187,479,256 | € 162,805,051 | € 174,902,250 | ▲ 7% |
| Dividend | € 0 | € 44,000,000 | € 0 | € 0 | |
| Bank debt | € 0 | € 0 | € 0 | € 27,960,840 | |
| Balance sheet total | € 767,746,203 | € 862,484,080 | € 862,440,211 | € 979,880,708 | ▲ 14% |
| Employees (FTE) | 757.7 | 753.5 | 775.1 | 721.3 | ▼ 53.8 |
Key figures of TERUMO EUROPE, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to TERUMO EUROPE?
What happened at TERUMO EUROPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 12.1 million. Source: NBB ↗
- Jin Hagimoto stepped down as director. NBB
- Hosokai Takuya stepped down as director. NBB
- Bhawna Menghnani stepped down as director. NBB
- Norimasa Kunimoto stepped down as director. NBB
- Itaru Sakaguchi stepped down as director. NBB
- Jin Hagimoto became a director. NBB
- Hosokai Takuya became a director. NBB
In short
From € 42.6 million profit in 2023 to € 12.1 million profit in 2026.
Paid € 37.5 million in corporate taxes since 2023.
Best year ever: 2024, with € 45.2 million profit.
Paid out € 44 million in dividends to the owners in total.
Management
The shares are held by Terumo Corporation (100%). It owns 100% of Terumo France SAS, 100% of Terumo Poland Sp Zo.o., 100% of Terumo Italia Srl, 100% of Terumo Deutschland GmbH, 100% of Vascutek Deutschland GmbH and 100% of Quirem Medical BV itself.
Directors
According to the 2026 annual accounts
Jin Hagimoto
Director
since 2025 · until 2026
Hosokai Takuya
Chairman of the board
since 2025 · until 2026
Bhawna Menghnani
Director
since 2025 · until 2026
Norimasa Kunimoto
Director
since 2025 · until 2026
Itaru Sakaguchi
Director
since 2025 · until 2026
Shareholders
Terumo Corporation
100%
Participations
Terumo France SAS
100%
Terumo Poland Sp Zo.o.
100%
Terumo Italia Srl
100%
Terumo Deutschland GmbH
100%
Vascutek Deutschland GmbH
100%
Quirem Medical BV
100%
Terumo Russia LLC
100%
Vascutek UK Limited
100%
Terumo Sweden AB
100%
Terumo Middle East FZE
100%
Terumo South Africa
100%
Terumo UK Ltd.
100%
Terumo Europe Espana Sl
100%
Establishments
Establishment units
Physical locations of this company
Interleuvenlaan 40
3001 Leuven
Brikkenovenstraat 48
3600 Genk
Active since 1 May 2010
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Domain
Domain
terumo-europe.com
Registered
1998-12-07
Registrar
Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA
Expires
2026-12-06
Website info
Features
Security
Details
- Company number
- 0408.270.327
- VAT number
- BE 0408.270.327
- Registered office
- Interleuvenlaan 40, 3001 Leuven
- Names & denominations
- TERUMO EUROPE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 5 May 1971
- Peppol
- Active · Active since 4 Sept 2025
- Contact
- terumo-europe.com 016381211
- Activities · NACE
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden
Vervaardiging van niet-elektrische apparaten en instrumenten voor de geneeskunde, de tandheelkunde en de veeartsenijkunde
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten